Status:
COMPLETED
HUmira in Psoriatic Arthritis
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Collaborating Sponsors:
University Hospital, Gentofte, Copenhagen
Copenhagen University Hospital at Herlev
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis, which has a estimated prevalence of 0.3 - 1 %. The clinical course varies, but PsA is often a progressive, erosive art...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subject Population: patients with active PsA, fulfilling the following major criteria:
- Diagnosis of PsA according to Moll and Wright criteria (Moll and Wright,
- Clinical active disease, defined as \>2 (of 76) swollen joints and \> 2 (of 78) tender joints
- Involvement of the hands (Clinical swelling of 1 or more finger joint and/or 1 or more 1 sausage finger)
- Clinical indication for anti-TNF alpha therapy, according to treating physician
- Among other issues: Age \>18 years; adequate birth control; no contraindications for anti-TNF alpha-therapy, no previous anti-TNF alpha-therapy, no other significant dermatological disorders than psoriasis.
Exclusion
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01465438
Start Date
November 1 2006
End Date
June 1 2011
Last Update
November 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen University Hospital, Glostrup
Glostrup Municipality, Copenhagen, Denmark, 2600